v3.25.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 11,909 $ 26,674
Restricted deposit 248 241
Trade receivables, net 150
Inventories 440 714
Other accounts receivable and prepaid expenses 433 393
Total current assets 13,180 28,022
Non-current assets:    
Restricted deposit 118 57
Operating lease right-of-use assets 2,991 3,070
Property and equipment, net 2,290 2,789
Intangible assets, net 131 188
Total non-current assets 5,530 6,104
Total assets 18,710 34,126
Current liabilities:    
Trade payables 870 980
Operating lease liabilities 806 624
Accrued liabilities and other payables 1,294 1,647
Total current liabilities 2,970 3,251
Non-current liabilities:    
Operating lease liabilities 2,275 2,535
Total non-current liabilities 2,275 2,535
Total liabilities 5,245 5,786
Commitments and contingencies  
Shareholders’ Equity:    
Ordinary shares, NIS 1.5 par value - authorized: 30,000,000 ordinary shares as of December 31, 2024 and 2023; issued and outstanding: 11,454,512 and 11,452,672 ordinary shares as of December 31, 2024 and 2023, respectively 4,983 4,982
Additional paid in capital 122,801 121,068
Accumulated other comprehensive loss (969) (969)
Accumulated deficit (113,350) (96,741)
Total shareholders’ equity 13,465 28,340
Total liabilities and shareholders’ equity $ 18,710 $ 34,126

Source